Radionuclide probes for molecular imaging of pancreatic beta-cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  2010-08-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.addr.2010.09.006PMID 20854861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [General concept and pathophysiological mechanisms of progression of macrovascular complications in diabetes].

  2010cited by this paper
• Neuroprotection in Diabetic Encephalopathy

  2010cited by this paper
• Clinical PET imaging of insulinoma and beta-cell hyperplasia.

  2010cited by this paper
• Diabetic retinopathy

  2010cited by this paper
• The utility of [(11)C] dihydrotetrabenazine positron emission tomography scanning in assessing beta-cell performance after sleeve gastrectomy and duodenal-jejunal bypass.

  2010cited by this paper
• MR imaging of pancreatic islets: tracking isolation, transplantation and function.

  2010cited by this paper
• Bioluminescence Imaging in Mouse Models Quantifies β Cell Mass in the Pancreas and After Islet Transplantation

  2010cited by this paper
• Assessment of Islet Specificity of Dihydrotetrabenazine Radiotracer Binding in Rat Pancreas and Human Pancreas

  2010cited by this paper
• Dual probe microPET imaging of rodent pancreas

  2010cited by this paper
• Diabetes und kardiovaskuläre Komplikationen

  2010cited by this paper
• Synthesis and evaluation of F-18-exendin as a potential biomarker to measure pancreatic beta-cell mass

  2010cited by this paper
• In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass.

  2010cited by this paper
• Dual Radiotracer Analysis of Cholinergic Neuronal Changes in Prediabetic Mouse Pancreas

  2009cited by this paper
• Chronic kidney disease in United States Hispanics: a growing public health problem.

  2009cited by this paper
• MRI as a tool to monitor islet transplantation

  2009cited by this paper
• MRI in diabetes: first results.

  2009cited by this paper
• Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.

  2009cited by this paper
• GLP-1 receptor antagonist as a potential probe for pancreatic beta-cell imaging.

  2009cited by this paper
• 18F-FDOPA: A Multiple-Target Molecule

  2009cited by this paper
• 18F-Fallypride PET to monitor pancreatic beta cell loss in diabetes mellitus

  2009cited by this paper
• Enhanced Cholinergic Response in Pancreata of Nonhuman Primates with Impaired Glucose Tolerance Shown on [18F]Fluorobenzyltrozamicol Positron Emission Tomography

  2009cited by this paper
• In vivo visualization of transplanted pancreatic islets by MRI: comparison between in vivo, histological and electron microscopy findings.

  2009cited by this paper
• Positron Emission Tomography in Clinical Islet Transplantation

  2009cited by this paper
• Sulfonylurea receptors and mechanism of sulfonylurea action.

  2009cited by this paper
• Advances in molecular imaging of pancreatic beta cells.

  2008cited by this paper
• A New Acycloguanosine-Specific Supermutant of Herpes Simplex Virus Type 1 Thymidine Kinase Suitable for PET Imaging and Suicide Gene Therapy for Potential Use in Patients Treated with Pyrimidine-Based Cytotoxic Drugs

  2008cited by this paper
• In Vivo Tracking of Dendritic Cells in Patients With Multiple Myeloma

  2008cited by this paper
• VMAT2 gene expression and function as it applies to imaging beta-cell mass.

  2008cited by this paper
• In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.

  2008cited by this paper
• In Vivo Imaging of β-Cell Mass in Rats Using 18F-FP-(+)-DTBZ: A Potential PET Ligand for Studying Diabetes Mellitus

  2008cited by this paper
• VMAT2 quantitation by PET as a biomarker for β‐cell mass in health and disease

  2008cited by this paper
• Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.

  2008cited by this paper
• Whole body [11C]-dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates

  2008cited by this paper
• Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors.

  2008cited by this paper
• VMAT2 gene expression and function as it applies to imaging β-cell mass

  2007cited by this paper
• The physiology of glucagon-like peptide 1.

  2007cited by this paper
• Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.

  2007cited by this paper
• The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children

  2007cited by this paper
• Imaging of Gene Expression in Live Pancreatic Islet Cell Lines Using Dual-Isotope SPECT

  2007cited by this paper
• [18F]Fluoro-L-DOPA PET/CT in Congenital Hyperinsulinism

  2007cited by this paper
• Role of imaging in cardiac stem cell therapy.

  2007cited by this paper
• Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.

  2007cited by this paper
• Synthesis and evaluation of a glibenclamide glucose-conjugate: a potential new lead compound for substituted glibenclamide derivatives as islet imaging agents.

  2007cited by this paper
• Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.

  2007cited by this paper
• Dynamic Tracking During Intracoronary Injection of 18F-FDG-Labeled Progenitor Cell Therapy for Acute Myocardial Infarction

  2007cited by this paper
• Biology of incretins: GLP-1 and GIP.

  2007cited by this paper
• In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma

  2006cited by this paper
• Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival

  2006cited by this paper
• A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents.

  2006cited by this paper
• Synthesis and evaluation of radioiodinated substituted β-naphthylalanine as a potential probe for pancreatic β-cells imaging

  2006cited by this paper
• Visualizing pancreatic β-cell mass with [11C]DTBZ

  2006cited by this paper
• Long-term monitoring of transplanted islets using positron emission tomography.

  2006cited by this paper
• A Novel Method of Monitoring Response to Islet Transplantation: Bioluminescent Imaging of an NF-kB Transgenic Mouse Model

  2006cited by this paper
• In vivo imaging of islet transplantation

  2006cited by this paper
• 18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers

  2006cited by this paper
• Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.

  2006cited by this paper
• Noninvasive imaging of islet grafts using positron-emission tomography.

  2006cited by this paper
• Current progress in non-invasive imaging of beta cell mass of the endocrine pancreas.

  2006cited by this paper
• Synthesis and evaluation of radioiodinated substituted beta-naphthylalanine as a potential probe for pancreatic beta-cells imaging.

  2006cited by this paper
• Preclinical safety evaluation of 18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk's expression.

  2006cited by this paper
• Imaging Islets Labeled With Magnetic Nanoparticles at 1.5 Tesla

  2006cited by this paper
• Visualizing pancreatic beta-cell mass with [11C]DTBZ.

  2006cited by this paper
• Quantitative evaluation of a monoclonal antibody and its fragment as potential markers for pancreatic beta cell mass.

  2005cited by this paper
• Bioluminescence imaging of nuclear calcium oscillations in intact pancreatic islets of Langerhans from the mouse.

  2005cited by this paper
• Peptide-mediated targeting of the islets of Langerhans.

  2005cited by this paper
• Positron-emission tomography imaging of early events after transplantation of islets of Langerhans.

  2005cited by this paper
• In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans.

  2005cited by this paper
• Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.

  2005cited by this paper
• Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model.

  2004cited by this paper
• Synthesis and evaluation of fluorine-18 labeled glyburide analogs as beta-cell imaging agents.

  2004cited by this paper
• Identification of tissue-restricted transcripts in human islets.

  2004cited by this paper
• Systematic screening of potential beta-cell imaging agents.

  2004cited by this paper
• Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide): a potential beta-cell imaging agent.

  2004cited by this paper
• Neurofunctional imaging of the pancreas utilizing the cholinergic PET radioligand [18F]4-fluorobenzyltrozamicol

  2004cited by this paper
• Systematic screening of potential β-cell imaging agents

  2004cited by this paper
• Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic β-cell mass with positron emission tomography (PET)

  2004cited by this paper
• Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).

  2004cited by this paper
• Expression of the Two Isoforms of the Vesicular Monoamine Transporter (VMAT1 and VMAT2) in the Endocrine Pancreas and Pancreatic Endocrine Tumors

  2003cited by this paper
• Gene expression profiling in islet biology and diabetes research

  2003cited by this paper
• Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates.

  2002cited by this paper
• Radiosynthesis of 1-(4-(2-[18F]fluoroethoxy)benzenesulfonyl)-3-butyl urea: a potential β-cell imaging agent

  2002cited by this paper
• Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression.

  2002cited by this paper
• Specific monoclonal antibodies against the surface of rat islet beta cells.

  2002cited by this paper
• SPECIFIC MONOCLONAL ANTIBODIES AGAINST THE SURFACE OF RAT ISLET β CELLS

  2002cited by this paper
• Pancreatic fate of D‐[3H] mannoheptulose

  2001cited by this paper
• On the track to the beta-cell

  2001cited by this paper
• Uptake of 1-deoxy-1-[125I]iodo-D-mannoheptulose by different cell types: in vitro and in vivo experiments.

  2001cited by this paper
• Assessment of islet beta-cell mass in isolated rat pancreases perfused with D-[(3)H]mannoheptulose.

  2001cited by this paper
• Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET.

  2001cited by this paper
• Pancreatic fate of a 125I‐labelled mouse monoclonal antibody directed against pancreatic B‐cell surface ganglioside(s) in control and diabetic rats

  2001cited by this paper
• Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes.

  2001cited by this paper
• Uptake of D-mannoheptulose by normal and tumoral pancreatic islet cells.

  2001cited by this paper
• Assessment of B-cell mass in isolated islets exposed to D-[3H]mannoheptulose.

  2001cited by this paper
• Uptake of tritiated D-mannoheptulose by liver, pancreatic exocrine and endocrine cells.

  2001cited by this paper
• Noninvasive In Vivo Measurement of β-Cell Mass in Mouse Model of Diabetes

  2001cited by this paper
• Assessment of islet β-cell mass in isolated rat pancreases perfused with d-[3H]mannoheptulose

  2001cited by this paper
• Synthesis of fluorine‐18 labeled sulfonureas as β‐cell imaging agents

  2001cited by this paper
• Fate of 2-deoxy-2-[18F]fluoro-D-glucose in control and diabetic rats.

  2000cited by this paper
• Fate of 2-deoxy-2-[18F]fluoro-D-glucose in hyperglycemic rats.

  2000cited by this paper
• Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes

  1999cited by this paper

• Generation of fluorescent and bioluminescent induced pluripotent stem cells with their application in tracking organoid development.

  2025cites this paper
• CHARACTERIZING NOVEL GLUCAGON-LIKE PEPTIDE-1 DERIVATIVES FOR NUCLEAR IMAGING OF THE PANCREATIC BETA CELLS

  2021cites this paper
• Chemical Biology Toolbox for Studying Pancreatic Islet Function - A Perspective.

  2020cites this paper
• Nanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment.

  2020influential citation
• Trideuteromethylation Enabled by a Sulfoxonium Metathesis Reaction.

  2019cites this paper
• Molecular imaging of diabetes and diabetic complications: Beyond pancreatic β-cell targeting.

  2019cites this paper
• Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

  2019cites this paper
• Molecular imaging of β-cells: diabetes and beyond.

  2019cites this paper
• Porphyrins and related macrocycles: Combining photosensitization with radio- or optical-imaging for next generation theranostic agents.

  2018cites this paper
• Imaging in Diabetes

  2018cites this paper
• Molecular Imaging Agent Design for Quantifying Beta Cell Mass in Type 1 Diabetes

  2017cites this paper
• PET probes for imaging pancreatic islet cells

  2017cites this paper
• Beta Cell Imaging as Part of “Imaging on Metabolic Diseases”

  2017cites this paper
• Imaging pancreatic islet cells by positron emission tomography

  2016cites this paper
• Improved β-Cell Targeting and Therapeutics Using Multivalent Glucagon-Like Peptide-1 (GLP-1) Linked to the α2AR Antagonist Yohimbine (YHB): Evaluating the Binding, Selectivity and Signaling

  2016cites this paper
• A porcine type 1 Diabetes Mellitus model, for non-invasive in vivo imaging of the glucagon-like peptide-1 receptor in the pancreas, using [68Ga]Ga-DO3A-VS-Cys40-conjugated synthetic exendin-4 in PET-CT

  2015cites this paper
• Diagnostic and prognostic utility of non-invasive imaging in diabetes management.

  2015cites this paper
• 6-[18F]Fluoro-l-DOPA Uptake in the Rat Pancreas is Dependent on the Tracer Metabolism

  2014cites this paper
• Managing diabetes with nanomedicine: challenges and opportunities

  2014cites this paper
• ¹²⁴I-Epidepride: a PET radiotracer for extended imaging of dopamine D2/D3 receptors.

  2014cites this paper
• Teemu Kalliokoski FUNCTIONAL IMAGING OF INSULITIS IN TYPE 1 DIABETES

  2014cites this paper
• Functional Imaging of Insulitis in Type 1 Diabetes

  2014cites this paper
• 64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats.

  2014cites this paper
• Imaging in the cardiovascular and metabolic disease area.

  2013cites this paper
• In Vivo Imaging of the Glucagonlike Peptide 1 Receptor in the Pancreas with 68Ga-Labeled DO3A-Exendin-4

  2013cites this paper
• Beta-Cell Imaging: Call for Evidence-Based and Scientific Approach

  2013cites this paper
• 64Cu- and 68Ga-Labelled [Nle14,Lys40(Ahx-NODAGA)NH2]-Exendin-4 for Pancreatic Beta Cell Imaging in Rats

  2013cites this paper
• Combinatorial Targeting of the Glucagon-Like Peptide-1 And Sulfonylurea-1 Receptors Using a Complimentary Multivalent Glucagon-Like Peptide-1/Glibenclamide Ligand for the Improvement of β-Cell Targeting Agents and Diabetic Treatment

  2013cites this paper
• Monitoring of clinical islet transplantation.

  2013cites this paper
• Molecular Imaging with Radiotracers : Current Status

  2012cites this paper
• Immune biomarkers in immunotherapeutic trials for type 1 diabetes: cui prodest?

  2012cites this paper
• Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors.

  2012cites this paper
• 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma

  2012cites this paper
• Imaging of hypoxia-inducible factor-1-active regions in tumors using a POS and 123I-IBB method

  2012cites this paper
• Trideuteriomethoxylation of Aryl and Heteroaryl Halides

  2012cites this paper
• Molecular imaging for diagnosis and management of diabetes - a review

  2012cites this paper
• 18F-Fallypride PET of Pancreatic Islets: In Vitro and In Vivo Rodent Studies

  2011cites this paper
• Noninvasive Imaging Techniques in Islet Transplantation

  2011cites this paper
• Clinical Molecular Imaging with Radiotracers: Current Status

  2011cites this paper
• Dual Radiotracer Analysis of Cholinergic Neuronal Changes in Prediabetic Mouse Pancreas

  2009cites this paper
• MRI in diabetes: first results.

  2009cites this paper